Login to Your Account



Merck Goes Shopping

Merck Buying GlycoFi For $400M, Abmaxis For $80M

By Karen Pihl-Carey


Wednesday, May 10, 2006
Merck & Co. Inc. set in motion two definitive agreements to acquire privately held biotechnology companies GlycoFi Inc. and Abmaxis Inc., and $400 million for $80 million, respectively, and would pay cash for both. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription